why choose us

First received: May 25, 2023

Clinical Trial: Postpartum ASA and NT-proBNP

Study Status: Completed

Recruit Status: RECRUITING

Condition: Blood Pressure

Study Type: INTERVENTIONAL


Official Title: The Association Between Postpartum Aspirin Use and NT-proBNP Levels as a Marker for Maternal Health Outcomes.

Brief Summary: This study is a double-blinded randomized-controlled trial in which patients will be randomized to 81 mg of aspirin or placebo to be continued for 6 weeks' postpartum.The purpose of this study is to compare NT-proBNP levels at the 4-6 week postpartum visit between groups.There is currently no data on the maternal health effects associated with continuation of low-dose aspirin in the postpartum period.This study aims to fill a gap in the knowledge regarding the utility of low-dose aspirin following delivery.

Read more